Kidney drug showdown: which combo wins for blood pressure and kidney protection?

NCT ID NCT07223502

First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 21 times

Summary

This study compares two different drug combinations to see which works better for people with both high blood pressure and chronic kidney disease. About 30 adults will be randomly assigned to take either finerenone alone or a fixed-dose combination of torsemide and spironolactone. The goal is to find which approach better lowers blood pressure, reduces protein in the urine (a sign of kidney damage), and keeps potassium levels safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sarfez Pharmaceuticals, Inc.

    RECRUITING

    Vienna, Virginia, 22182, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.